Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Huleatt

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Expression and function of synaptotagmin VII in CTLsKimberly T Fowler, Norma W Andrews, James W Huleatt
Immunology|April 2, 2003
P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawalJames W Huleatt, James Cresswell, Kim Bottomly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine modelXiu-Min Li, Kamal Srivastava, James W Huleatt, et al.
The Journal of Experimental Medicine|December 18, 2002
Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigenStephanie C Eisenbarth, Damani A Piggott, James W Huleatt, et al.
The Journal of Clinical Investigation|January 15, 2005
MyD88-dependent induction of allergic Th2 responses to intranasal antigenDamani A Piggott, Stephanie C Eisenbarth, Lan Xu, et al.
Vaccine|September 14, 2006
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunityJames W Huleatt, Andrea R Jacobs, Jie Tang, et al.
Journal of Virological Methods|March 24, 2018
Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virusEduardo J M Nascimento, James K George, Melissa Velasco, et al.
The American Journal of Tropical Medicine and Hygiene|August 9, 2019
Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic AreasEduardo J M Nascimento, Matthew I Bonaparte, Ping Luo, et al.
Vaccine|December 8, 2007
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellinJames W Huleatt, Valerian Nakaar, Priyanka Desai, et al.
Journal of Virological Methods|April 24, 2018
Development of antibody biomarkers of long term and recent dengue virus infectionsEduardo J M Nascimento, James W Huleatt, Marli T Cordeiro, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Expression and function of synaptotagmin VII in CTLsKimberly T Fowler, Norma W Andrews, James W Huleatt
Immunology|April 2, 2003
P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawalJames W Huleatt, James Cresswell, Kim Bottomly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine modelXiu-Min Li, Kamal Srivastava, James W Huleatt, et al.
The Journal of Experimental Medicine|December 18, 2002
Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigenStephanie C Eisenbarth, Damani A Piggott, James W Huleatt, et al.
The Journal of Clinical Investigation|January 15, 2005
MyD88-dependent induction of allergic Th2 responses to intranasal antigenDamani A Piggott, Stephanie C Eisenbarth, Lan Xu, et al.
Vaccine|September 14, 2006
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunityJames W Huleatt, Andrea R Jacobs, Jie Tang, et al.
Journal of Virological Methods|March 24, 2018
Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virusEduardo J M Nascimento, James K George, Melissa Velasco, et al.
The American Journal of Tropical Medicine and Hygiene|August 9, 2019
Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic AreasEduardo J M Nascimento, Matthew I Bonaparte, Ping Luo, et al.
Vaccine|December 8, 2007
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellinJames W Huleatt, Valerian Nakaar, Priyanka Desai, et al.
Journal of Virological Methods|April 24, 2018
Development of antibody biomarkers of long term and recent dengue virus infectionsEduardo J M Nascimento, James W Huleatt, Marli T Cordeiro, et al.
Pageof 2